April 22, 2019 / 10:50 PM / a month ago

Drugmaker Synergy says Ch. 11 plan has full support of key creditors

Gastrointestinal therapies developer Synergy Pharmaceuticals Inc will ask a judge on Tuesday to approve its plan to wrap up its bankruptcy and distribute proceeds from its $200 million sale.

New York-headquartered Synergy sought Chapter 11 protection in December with a deal to be acquired by Canadian health products maker Bausch Health Companies Inc for $200 million in cash and assuming some liabilities.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2UNjPQq

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below